Hoechst Pakistan Limited

PSX-HPL
Pakistan Stock Exchange NYSE
Pharmaceutical Preparations
Global Rank
#23820
Country Rank
#87
Market Cap
108.31 M
Price
11.23
Change (%)
1.08%
Volume
53

Hoechst Pakistan Limited's latest marketcap:

108.31 M

As of 06/08/2025, Hoechst Pakistan Limited's market capitalization has reached $108.31 M. According to our data, Hoechst Pakistan Limited is the 23820th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 108.31 M
Revenue (ttm) 97.98 M
Net Income (ttm) 7.25 M
Shares Out 9.64 M
EPS (ttm) 0.75
Forward PE 0.00
Ex-Dividend Date 03/26/2025
Earnings Date 08/22/2025
Market Cap Chart
Data Updated: 06/08/2025

Hoechst Pakistan Limited's yearly market capitalization.

Hoechst Pakistan Limited has seen its market value grow from rs7.3 B to rs30.99 B since 2020, representing a total increase of 324.25% and an annual compound growth rate (CAGR) of 38.51%.
Date Market Cap Change (%)
06/08/2025 rs30.99 B 14.75%
12/31/2024 rs27.01 B 133.33%
12/29/2023 rs11.57 B 25.26%
12/29/2022 rs9.24 B 6.72%
12/31/2021 rs8.66 B 18.53%
12/31/2020 rs7.3 B

Company Profile

About Hoechst Pakistan Limited

Hoechst Pakistan Limited is a leading pharmaceutical company engaged in the manufacture, trading, and sale of pharmaceutical and healthcare products. It operates in Pakistan, Afghanistan, and international markets, delivering high-quality medical solutions.

Product Portfolio

The company offers a diverse range of pharmaceutical products across multiple therapeutic categories, including:

  • Allergy Management – Flagyl, Secnidazole Forte
  • Cardiology – Cordarone, CoAprovel, Aprovel
  • Diabetes Care – Lantus, Amaryl, Daonil
  • Antibiotics – Claforan, Targocid, Tavanic
  • Emergency Care – Haemaccel, Lasix
  • Consumer Healthcare – Selsun Blue, Enterogermina

Corporate Background

Originally established as Sanofi-Aventis Pakistan Limited, the company rebranded to Hoechst Pakistan Limited in September 2023. Founded in 1967, it is headquartered in Karachi, Pakistan, and continues to be a key player in the pharmaceutical industry.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.